Osteoarthritis Drugs Market Trends

Osteoarthritis Drugs Market Trends

• The market growth is owing to increasing elderly population base that are more prone to osteoarthritis. For instance, as highlighted in a PubMed Central article from September 2022, osteoarthritis stands out as a leading cause of disability, affecting nearly 10% of the global population aged 60 years and older. This rise in the geriatric population has led to a greater focus on geriatric healthcare, including the development of specialized treatments and medications tailored to the needs of older patient.
   
• Thus, pharmaceutical companies are investing in research and development efforts to create innovative therapies that address the unique challenges of treating osteoarthritis in elderly patients, thereby fostering the market growth.